T1	Participants 662 698	patients with essential hypertension
T2	Participants 724 742	healthy volunteers
T3	Participants 808 873	85 newly diagnosed patients with untreated essential hypertension
T4	Participants 1030 1124	42 patients were randomized into the valsartan group and 43 patients into the amlodipine group
